Sai Life Sciences
add_icon

Sai Life Sciences

825.95
-9.20
(-1.10%)
Market Cap
17,373.20 Cr
PE Ratio
61.59
Volume
29,577.00
Day High - Low
833.20 - 812.70
52W High-Low
983.35 - 636.10
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
17,373.20 Cr
EPS
8.83
PE Ratio
61.59
PB Ratio
7.77
Book Value
107.46
EBITDA
442.40
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
7.99
Debt to Equity
0.41
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Sai Life Sciences announces strategic partnership with Mabtech to enhance immunology research capabilities, establishes Boston laboratory as US hub for Eyra platform, and expands advanced immunology assay services.
neutral
Sai Life Sciences schedules earnings conference call for February 6, 2026 at 4:00 PM IST to discuss Q3FY26 unaudited financial results for quarter and nine months ended December 31, 2025.
negative
Sai Life Sciences Limited received warning letters from BSE and NSE for not holding mandatory Stakeholders' Relationship Committee meetings during FY2024-25, citing short duration between listing date and year-end.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,625.60
#1 3,90,035.89
36.50
#1 54,729.00
9.71
#1 10,980
16.07
29.61
6,050.00
1,60,608.49
64.68
9,712.00
18.67
2,191
35.10
38.59
3,975.20
1,34,538.83
62.62
11,539.40
6.99
1,911
30.46
52.91
1,321.50
1,06,747.04
23.59
28,409.50
7.12
5,291
-57.18
23.33
1,216.40
1,01,524.44
18.41
33,741.20
16.73
5,725
-15.28
48.44
2,134.50
97,503.71
22.61
22,909.50
13.74
3,306
#1 72.75
53.14
883.35
88,885.68
#1 17.71
23,511.00
18.55
4,615
34.60
42.62
2,108.00
87,019.31
49.45
12,744.20
#1 20.90
2,007
-21.05
44.73
1,183.30
68,726.26
20.58
32,345.60
9.43
3,484
3.81
58.30
5,615.50
67,141.73
28.14
13,458.30
3.70
2,216
10.98
47.70

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
15.86 %
Net Income Growth
105.43 %
Cash Flow Change
19.37 %
ROE
-5.89 %
ROCE
-1.49 %
EBITDA Margin (Avg.)
21.38 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
395
443
288
406
449
589
506
553
Expenses
287
315
254
293
320
422
376
392
EBITDA
108
128
34
112
129
167
131
161
Operating Profit %
25 %
28 %
9 %
26 %
27 %
27 %
24 %
27 %
Depreciation
31
31
31
36
34
38
38
40
Interest
23
21
21
21
23
11
12
9
Profit Before Tax
53
76
-18
55
72
119
81
112
Tax
13
20
-5
14
18
31
20
28
Net Profit
40
56
-14
42
54
88
61
84
EPS in ₹
2.19
31.00
-0.74
2.22
2.89
4.24
2.90
4.01

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
1,216
1,410
1,817
2,157
2,187
2,275
3,160
Fixed Assets
374
641
753
751
1,037
1,180
1,488
Current Assets
691
613
804
944
964
945
1,505
Capital Work in Progress
116
91
194
410
151
107
125
Investments
0
0
0
0
2
2
2
Other Assets
726
679
870
997
997
987
1,545
Total Liabilities
1,216
1,410
1,817
2,157
2,187
2,275
3,160
Current Liabilities
336
467
599
713
759
740
733
Non Current Liabilities
160
149
356
565
540
560
299
Total Equity
720
794
863
879
888
975
2,128
Reserve & Surplus
703
777
845
861
870
957
2,108
Share Capital
16
16
18
18
18
18
21

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
239
-150
-1
75
-80
-24
79
Investing Activities
-158
-262
-260
-102
-99
-191
-536
Operating Activities
129
116
-36
105
219
263
314
Financing Activities
268
-4
296
72
-201
-95
301

Share Holding

% Holding
Jul 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter
39.64 %
35.24 %
35.24 %
35.17 %
35.15 %
34.93 %
34.70 %
FIIs
0.00 %
7.64 %
11.72 %
12.36 %
14.58 %
22.49 %
21.40 %
DIIs
0.00 %
5.61 %
11.95 %
13.26 %
21.64 %
29.94 %
31.41 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
18.68 %
8.88 %
7.69 %
6.56 %
7.90 %
5.95 %
Others
60.36 %
32.84 %
32.22 %
31.52 %
22.07 %
4.74 %
6.54 %
No of Share Holders
70
5,72,970
82
1,40,677
1,26,380
1,19,704
1,14,820

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
05 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2026 808.30 835.15
06 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Feb 2025 695.75 694.80
13 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 May 2025 717.70 713.35
07 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Aug 2025 815.20 792.85
11 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
11 Sept 2025 791.55 861.70
06 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
06 Nov 2025 892.85 923.20

Announcements

Announcement under Regulation 30 (LODR)-Press Release / Media Release3 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation3 days ago
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results For The Third Quarter And Nine Months Ended December 31 2025.9 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Intimation Of Receipt Of Letter From BSE Dated 06 January 2026 And NSE Dated 07 January 2026.Jan 07, 2026
Receipt Of An Order Dated 30Th December 2025 Passed By The Additional Commissioner Ranga Reddy GST Commissionerate Hyderabad U/S 74 Of The Central Goods And Services Tax Act 2017Dec 31, 2025
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 19, 2025
An Order Dated 09Th December 2025 Was Passed By The Deputy Commissioner Of Commercial Taxes (Audit) Bidar DGSTO Kalaburagi U/S 73(9) Of The Integrated Goods And Services Tax Act 2017.Dec 11, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 08, 2025
An Order Dated 06Th December 2025 Has Been Passed By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi Under Section 107(11) Of The Karnataka Goods And Services Tax Act 2017.Dec 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 23, 2025
Intimation For Order Dated 19Th November 2025 Issued By The Joint Commissioner Of Commercial Taxes (Appeals) Kalaburagi U/S 107 (11) Of The Karnataka Goods And Services Tax Act 2017 And The Central Goods And Services Tax Act 2017.Nov 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Intimation Of Order Dated 12Th November 2025 Passed By The Assistant Commissioner Central Tax Division-II (Pimpri) Pune-I Commissionerate U/S 74 Of The CGST Act 2017.Nov 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 11, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 08, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 07, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 06, 2025
Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended On 30 September 2025Nov 06, 2025
Board Meeting Outcome for For Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended On 30 September 2025Nov 06, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSNov 04, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 24, 2025
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results (Standalone And Consolidated) For The Quarter Ended 30 September 2025.Oct 24, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSOct 17, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Oct 14, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Closure of Trading WindowSep 29, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 19, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 17, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 15, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementSep 11, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 11, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMSep 11, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSSep 03, 2025
Corrigendum To The Notice Of The 26Th Annual General Meeting.Sep 03, 2025
Company -UpdatesSep 03, 2025
Company-UpdatesSep 02, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Aug 30, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 28, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 23, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
HDFC Innovation Fund Direct-Growth
1.55%
-29244
-0.02%
-0.11%
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth
0.62%
5856
0.18%
0.17%
DSP Nifty Smallcap 250 Index Fund Direct - Growth
0.62%
527
0.62%
0.62%
Navi Nifty MidSmallcap 400 Index Fund Direct - Growth
0.21%
261
0.21%
0.21%
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.06%
105
0.02%
0.02%
ITI Mid Cap Fund Direct - Growth
1.08%
0
0.00%
0.01%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
2.01%
0
0.00%
0.09%
Aditya Birla Sun Life ELSS Tax Saver Direct-Growth
0.41%
0
0.00%
0.02%
Aditya Birla Sun Life Equity Savings Fund Direct-Growth
0.00%
0
0.00%
-0.12%
ITI Small Cap Fund Direct-Growth
1.04%
0
0.00%
0.04%
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth
0.41%
0
0.00%
0.01%
Aditya Birla Sun Life Multi-Cap Fund Direct-Growth
0.89%
0
0.00%
0.03%
ITI Pharma and Healthcare Fund Direct - Growth
1.61%
0
0.00%
0.09%
Aditya Birla Sun Life Retirement Fund - The 40s Plan Direct-Growth
1.18%
0
0.00%
0.04%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
2.26%
0
0.00%
0.11%
Angel One Nifty Total Market Index Fund Direct - Growth
0.06%
0
0.00%
0.02%
Axis Flexi Cap Fund Direct-Growth
0.78%
0
0.00%
0.04%
Axis India Manufacturing Fund Direct-Growth
0.69%
0
0.00%
0.03%
Axis Innovation Fund Direct-Growth
1.77%
0
0.00%
0.05%
Axis Multicap Fund Direct-Growth
0.80%
0
0.00%
0.02%
Axis Nifty 500 Index Fund Direct-Growth
0.06%
0
0.00%
0.02%
Axis Small Cap Fund Direct-Growth
1.29%
0
0.00%
0.04%
Bandhan Balanced Advantage Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.91%
0
0.00%
0.26%
Bandhan Healthcare Fund Direct - Growth
1.83%
0
0.01%
1.83%

Technical Indicators

RSI(14)
Neutral
42.95
ATR(14)
Less Volatile
31.33
STOCH(9,6)
Neutral
28.89
STOCH RSI(14)
Neutral
42.23
MACD(12,26)
Bearish
-5.79
ADX(14)
Weak Trend
23.12
UO(9)
Bearish
48.86
ROC(12)
Downtrend And Accelerating
-6.51
WillR(14)
Neutral
-73.10